A Multicenter, Randomized, Controlled Clinical Study on the Feasibility and Safety of Gasless Transaxillary Posterior Endoscopic and Open Thyroidectomy for Papillary Thyroid Cancer.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To evaluate the feasibility and safety of gasless transaxillary posterior endoscopic thyroidectomy (Resection of thyroid lobe and isthmus, lymph node dissection in the central area of the affected side) and open radical thyroidectomy (Resection of thyroid lobe and isthmus, lymph node dissection in the central area of the affected side) as the current standard surgical treatment mode in terms of feasibility and safety of radical thyroidectomy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• The patient's informed consent;

• 18 years old \< age \< 70 years old;

• Papillary thyroid carcinoma (Bethesda grade V-VI) was pathologically diagnosed by fine needle aspiration biopsy of the primary thyroid tumor before surgery;

• Color Doppler TI-RADS 4c-5 of primary thyroid tumor;

• The preoperative clinical staging is T1, N0-1a, M0 (see diagnostic criteria for details; according to AJCC-8th TNM tumor staging);

• It is expected that R0 surgical results can be obtained by performing single thyroid lobectomy and isthmus resection + ipsilateral central lymph node dissection;

• Preoperative ASA score I-III.

Locations
Other Locations
China
Nanfang Hospital of Southern Medical University
RECRUITING
Guangzhou
Contact Information
Primary
Baihui Sun, Dr.
sunbh_nfyy@163.com
+8602062787170
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2025-05-31
Participants
Target number of participants: 290
Treatments
Experimental: Study Group
Gasless Transaxillary Posterial Endoscopic Thyroidectomy and Ipsilateral Central Lymph Node Dissection
Active_comparator: Control Group
Conventional Open Thyroidectomy and Ipsilateral Central Lymph Node Dissection
Sponsors
Leads: Nanfang Hospital, Southern Medical University

This content was sourced from clinicaltrials.gov